| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |